Related Experiment Video
Updated: May 5, 2026

15:17
Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
Published on: September 25, 2011
14.4K
Are We There Yet? The Telltale Trail of ctDNA in Rectal Cancer
Alisha H Bent1, Arvind Dasari1, J Joshua Smith2
1Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Abstract:
ctDNA has emerged as a noninvasive diagnostic and prognostic tool for colorectal cancer. The role of ctDNA in total neoadjuvant therapy and nonoperative management of locally advanced rectal cancer is uncertain. In this study, we discuss a ctDNA biomarker analysis of rectal cancer patients undergoing neoadjuvant therapy from the NOMINATE trial. See related article by Akiyoshi et al., p. 5188.

